APA (7th ed.) Citation

Evans, D., Hirasen, K., Ramushu, C., Long, L., Sinanovic, E., Conradie, F., . . . Ndjeka, N. (2024). Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis. PLoS ONE, 19(10), 1. https://doi.org/10.1371/journal.pone.0309034

Chicago Style (17th ed.) Citation

Evans, Denise, et al. "Patient and Provider Costs of the New BPaL Regimen for Drug-resistant Tuberculosis Treatment in South Africa: A Cost-effectiveness Analysis." PLoS ONE 19, no. 10 (2024): 1. https://doi.org/10.1371/journal.pone.0309034.

MLA (9th ed.) Citation

Evans, Denise, et al. "Patient and Provider Costs of the New BPaL Regimen for Drug-resistant Tuberculosis Treatment in South Africa: A Cost-effectiveness Analysis." PLoS ONE, vol. 19, no. 10, 2024, p. 1, https://doi.org/10.1371/journal.pone.0309034.